TrueNTH sexual recovery study protocol: A multi-institutional collaborative approach to developing and testing a web-based intervention for couples coping with the side-effects of prostate cancer treatment in a randomized controlled trial

D. Wittmann, A. Mehta, L. Northouse, R. Dunn, T. Braun, A. Duby, L. An, L. Arab, R. Bangs, S. Bober, J. Brandon, M. Coward, M. Dunn, M. Galbraith, M. Garcia, J. Giblin, M. Glode, B. Koontz, A. Lowe, S. MitchellJ. Mulhall, C. Nelson, K. Paich, C. Saigal, T. Skolarus, J. Stanford, T. Walsh, Craig Pollack

Research output: Contribution to journalArticle

Abstract

Background: Over half of men who receive treatment for prostate suffer from a range of sexual problems that affect negatively their sexual health, sexual intimacy with their partners and their quality of life. In clinical practice, however, care for the sexual side effects of treatment is often suboptimal or unavailable. The goal of the current study is to test a web-based intervention to support the recovery of sexual intimacy of prostate cancer survivors and their partners after treatment. Methods: The study team developed an interactive, web-based intervention, tailored to type of treatment received, relationship status (partnered/non-partnered) and sexual orientation. It consists of 10 modules, six follow the trajectory of the illness and four are theme based. They address sexual side effects, rehabilitation, psychological impacts and coaching for self-efficacy. Each includes a video to engage participants, psychoeducation and activities completed by participants on the web. Tailored strategies for identified concerns are sent by email after each module. Six of these modules will be tested in a randomized controlled trial and compared to usual care. Men with localized prostate cancer with partners will be recruited from five academic medical centers. These couples (N = 140) will be assessed prior to treatment, then 3 months and 6 months after treatment. The primary outcome will be the survivors' and partners' Global Satisfaction with Sex Life, assessed by a Patient Reported Outcome Measure Information Systems (PROMIS) measure. Secondary outcomes will include interest in sex, sexual activity, use of sexual aids, dyadic coping, knowledge about sexual recovery, grief about the loss of sexual function, and quality of life. The impact of the intervention on the couple will be assessed using the Actor-Partner Interaction Model, a mixed-effects linear regression model able to estimate both the association of partner characteristics with partner and patient outcomes and the association of patient characteristics with both outcomes. Discussion: The web-based tool represents a novel approach to addressing the sexual health needs of prostate cancer survivors and their partners that-if found efficacious-will improve access to much needed specialty care in prostate cancer survivorship. Trial registration:Clinicaltrials.govregistration # NCT02702453 , registered on March 3, 2016.

Original languageEnglish (US)
Article number664
JournalBMC Cancer
Volume17
Issue number1
DOIs
StatePublished - Oct 2 2017

Fingerprint

Prostatic Neoplasms
Randomized Controlled Trials
Survivors
Reproductive Health
Sexual Behavior
Linear Models
Therapeutics
Quality of Life
Grief
Self Efficacy
Information Systems
Prostate
Rehabilitation
Survival Rate
Psychology

Keywords

  • Prostate cancer sexual recovery cancer survivorship intervention

ASJC Scopus subject areas

  • Oncology
  • Genetics
  • Cancer Research

Cite this

TrueNTH sexual recovery study protocol : A multi-institutional collaborative approach to developing and testing a web-based intervention for couples coping with the side-effects of prostate cancer treatment in a randomized controlled trial. / Wittmann, D.; Mehta, A.; Northouse, L.; Dunn, R.; Braun, T.; Duby, A.; An, L.; Arab, L.; Bangs, R.; Bober, S.; Brandon, J.; Coward, M.; Dunn, M.; Galbraith, M.; Garcia, M.; Giblin, J.; Glode, M.; Koontz, B.; Lowe, A.; Mitchell, S.; Mulhall, J.; Nelson, C.; Paich, K.; Saigal, C.; Skolarus, T.; Stanford, J.; Walsh, T.; Pollack, Craig.

In: BMC Cancer, Vol. 17, No. 1, 664, 02.10.2017.

Research output: Contribution to journalArticle

Wittmann, D, Mehta, A, Northouse, L, Dunn, R, Braun, T, Duby, A, An, L, Arab, L, Bangs, R, Bober, S, Brandon, J, Coward, M, Dunn, M, Galbraith, M, Garcia, M, Giblin, J, Glode, M, Koontz, B, Lowe, A, Mitchell, S, Mulhall, J, Nelson, C, Paich, K, Saigal, C, Skolarus, T, Stanford, J, Walsh, T & Pollack, C 2017, 'TrueNTH sexual recovery study protocol: A multi-institutional collaborative approach to developing and testing a web-based intervention for couples coping with the side-effects of prostate cancer treatment in a randomized controlled trial', BMC Cancer, vol. 17, no. 1, 664. https://doi.org/10.1186/s12885-017-3652-3
Wittmann, D. ; Mehta, A. ; Northouse, L. ; Dunn, R. ; Braun, T. ; Duby, A. ; An, L. ; Arab, L. ; Bangs, R. ; Bober, S. ; Brandon, J. ; Coward, M. ; Dunn, M. ; Galbraith, M. ; Garcia, M. ; Giblin, J. ; Glode, M. ; Koontz, B. ; Lowe, A. ; Mitchell, S. ; Mulhall, J. ; Nelson, C. ; Paich, K. ; Saigal, C. ; Skolarus, T. ; Stanford, J. ; Walsh, T. ; Pollack, Craig. / TrueNTH sexual recovery study protocol : A multi-institutional collaborative approach to developing and testing a web-based intervention for couples coping with the side-effects of prostate cancer treatment in a randomized controlled trial. In: BMC Cancer. 2017 ; Vol. 17, No. 1.
@article{24c939d7bb2a4dc1aa066324a81be837,
title = "TrueNTH sexual recovery study protocol: A multi-institutional collaborative approach to developing and testing a web-based intervention for couples coping with the side-effects of prostate cancer treatment in a randomized controlled trial",
abstract = "Background: Over half of men who receive treatment for prostate suffer from a range of sexual problems that affect negatively their sexual health, sexual intimacy with their partners and their quality of life. In clinical practice, however, care for the sexual side effects of treatment is often suboptimal or unavailable. The goal of the current study is to test a web-based intervention to support the recovery of sexual intimacy of prostate cancer survivors and their partners after treatment. Methods: The study team developed an interactive, web-based intervention, tailored to type of treatment received, relationship status (partnered/non-partnered) and sexual orientation. It consists of 10 modules, six follow the trajectory of the illness and four are theme based. They address sexual side effects, rehabilitation, psychological impacts and coaching for self-efficacy. Each includes a video to engage participants, psychoeducation and activities completed by participants on the web. Tailored strategies for identified concerns are sent by email after each module. Six of these modules will be tested in a randomized controlled trial and compared to usual care. Men with localized prostate cancer with partners will be recruited from five academic medical centers. These couples (N = 140) will be assessed prior to treatment, then 3 months and 6 months after treatment. The primary outcome will be the survivors' and partners' Global Satisfaction with Sex Life, assessed by a Patient Reported Outcome Measure Information Systems (PROMIS) measure. Secondary outcomes will include interest in sex, sexual activity, use of sexual aids, dyadic coping, knowledge about sexual recovery, grief about the loss of sexual function, and quality of life. The impact of the intervention on the couple will be assessed using the Actor-Partner Interaction Model, a mixed-effects linear regression model able to estimate both the association of partner characteristics with partner and patient outcomes and the association of patient characteristics with both outcomes. Discussion: The web-based tool represents a novel approach to addressing the sexual health needs of prostate cancer survivors and their partners that-if found efficacious-will improve access to much needed specialty care in prostate cancer survivorship. Trial registration:Clinicaltrials.govregistration # NCT02702453 , registered on March 3, 2016.",
keywords = "Prostate cancer sexual recovery cancer survivorship intervention",
author = "D. Wittmann and A. Mehta and L. Northouse and R. Dunn and T. Braun and A. Duby and L. An and L. Arab and R. Bangs and S. Bober and J. Brandon and M. Coward and M. Dunn and M. Galbraith and M. Garcia and J. Giblin and M. Glode and B. Koontz and A. Lowe and S. Mitchell and J. Mulhall and C. Nelson and K. Paich and C. Saigal and T. Skolarus and J. Stanford and T. Walsh and Craig Pollack",
year = "2017",
month = "10",
day = "2",
doi = "10.1186/s12885-017-3652-3",
language = "English (US)",
volume = "17",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - TrueNTH sexual recovery study protocol

T2 - A multi-institutional collaborative approach to developing and testing a web-based intervention for couples coping with the side-effects of prostate cancer treatment in a randomized controlled trial

AU - Wittmann, D.

AU - Mehta, A.

AU - Northouse, L.

AU - Dunn, R.

AU - Braun, T.

AU - Duby, A.

AU - An, L.

AU - Arab, L.

AU - Bangs, R.

AU - Bober, S.

AU - Brandon, J.

AU - Coward, M.

AU - Dunn, M.

AU - Galbraith, M.

AU - Garcia, M.

AU - Giblin, J.

AU - Glode, M.

AU - Koontz, B.

AU - Lowe, A.

AU - Mitchell, S.

AU - Mulhall, J.

AU - Nelson, C.

AU - Paich, K.

AU - Saigal, C.

AU - Skolarus, T.

AU - Stanford, J.

AU - Walsh, T.

AU - Pollack, Craig

PY - 2017/10/2

Y1 - 2017/10/2

N2 - Background: Over half of men who receive treatment for prostate suffer from a range of sexual problems that affect negatively their sexual health, sexual intimacy with their partners and their quality of life. In clinical practice, however, care for the sexual side effects of treatment is often suboptimal or unavailable. The goal of the current study is to test a web-based intervention to support the recovery of sexual intimacy of prostate cancer survivors and their partners after treatment. Methods: The study team developed an interactive, web-based intervention, tailored to type of treatment received, relationship status (partnered/non-partnered) and sexual orientation. It consists of 10 modules, six follow the trajectory of the illness and four are theme based. They address sexual side effects, rehabilitation, psychological impacts and coaching for self-efficacy. Each includes a video to engage participants, psychoeducation and activities completed by participants on the web. Tailored strategies for identified concerns are sent by email after each module. Six of these modules will be tested in a randomized controlled trial and compared to usual care. Men with localized prostate cancer with partners will be recruited from five academic medical centers. These couples (N = 140) will be assessed prior to treatment, then 3 months and 6 months after treatment. The primary outcome will be the survivors' and partners' Global Satisfaction with Sex Life, assessed by a Patient Reported Outcome Measure Information Systems (PROMIS) measure. Secondary outcomes will include interest in sex, sexual activity, use of sexual aids, dyadic coping, knowledge about sexual recovery, grief about the loss of sexual function, and quality of life. The impact of the intervention on the couple will be assessed using the Actor-Partner Interaction Model, a mixed-effects linear regression model able to estimate both the association of partner characteristics with partner and patient outcomes and the association of patient characteristics with both outcomes. Discussion: The web-based tool represents a novel approach to addressing the sexual health needs of prostate cancer survivors and their partners that-if found efficacious-will improve access to much needed specialty care in prostate cancer survivorship. Trial registration:Clinicaltrials.govregistration # NCT02702453 , registered on March 3, 2016.

AB - Background: Over half of men who receive treatment for prostate suffer from a range of sexual problems that affect negatively their sexual health, sexual intimacy with their partners and their quality of life. In clinical practice, however, care for the sexual side effects of treatment is often suboptimal or unavailable. The goal of the current study is to test a web-based intervention to support the recovery of sexual intimacy of prostate cancer survivors and their partners after treatment. Methods: The study team developed an interactive, web-based intervention, tailored to type of treatment received, relationship status (partnered/non-partnered) and sexual orientation. It consists of 10 modules, six follow the trajectory of the illness and four are theme based. They address sexual side effects, rehabilitation, psychological impacts and coaching for self-efficacy. Each includes a video to engage participants, psychoeducation and activities completed by participants on the web. Tailored strategies for identified concerns are sent by email after each module. Six of these modules will be tested in a randomized controlled trial and compared to usual care. Men with localized prostate cancer with partners will be recruited from five academic medical centers. These couples (N = 140) will be assessed prior to treatment, then 3 months and 6 months after treatment. The primary outcome will be the survivors' and partners' Global Satisfaction with Sex Life, assessed by a Patient Reported Outcome Measure Information Systems (PROMIS) measure. Secondary outcomes will include interest in sex, sexual activity, use of sexual aids, dyadic coping, knowledge about sexual recovery, grief about the loss of sexual function, and quality of life. The impact of the intervention on the couple will be assessed using the Actor-Partner Interaction Model, a mixed-effects linear regression model able to estimate both the association of partner characteristics with partner and patient outcomes and the association of patient characteristics with both outcomes. Discussion: The web-based tool represents a novel approach to addressing the sexual health needs of prostate cancer survivors and their partners that-if found efficacious-will improve access to much needed specialty care in prostate cancer survivorship. Trial registration:Clinicaltrials.govregistration # NCT02702453 , registered on March 3, 2016.

KW - Prostate cancer sexual recovery cancer survivorship intervention

UR - http://www.scopus.com/inward/record.url?scp=85030661581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030661581&partnerID=8YFLogxK

U2 - 10.1186/s12885-017-3652-3

DO - 10.1186/s12885-017-3652-3

M3 - Article

C2 - 28969611

AN - SCOPUS:85030661581

VL - 17

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

IS - 1

M1 - 664

ER -